Archives

by in
Entry Author Date Location
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
Effector Therapeutics Raises $45M to Prove New Concept in Cancer 05/21/13 San Diego
San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts 05/06/13 San Diego
San Diego Life Sciences Roundup: Topera, Afraxis, Trovagene, & More 05/03/13 San Diego
Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS 05/02/13 Texas
Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration 05/02/13 San Diego
San Diego Life Sciences Roundup: Avalon’s GSK Deal, Illumina, & More 04/25/13 San Diego
GlaxoSmithKline and Avalon Ventures Agree to Startup Collaboration 04/22/13 San Diego
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
Rare FDA Ruling Triggers Stampede for Acadia Pharmaceuticals 04/11/13 San Diego
San Diego’s Ambrx Working with Astellas to Develop Anti-Cancer Drugs 04/08/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
San Diego Life Sciences Roundup: Halozyme, Acadia, Trovagene, & More 03/29/13 San Diego
Still Waiting for the Ships to Come in at Third Rock Ventures 03/28/13 San Diego
New Domain Partnership Focuses on China’s Emerging Healthcare Market 03/13/13 San Diego
With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs 02/25/13 Boston
Sophiris Bio Files $75M IPO, Plans Pivotal Trials of Prostate Drug 02/19/13 San Diego
Elcelyx Closes on $20M to Advance Appetite-Control Compounds 02/14/13 San Diego
Hyperion’s Pinpoint Mission Pays Off with Drug Approval 02/06/13 San Francisco
California Stem Cell Agency Shifts Focus to Clinical Treatments 01/31/13 San Francisco
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
FDA OKs First-in-Class Drug From Isis for Rare Cholesterol Disorder 01/29/13 San Diego
Afraxis Licenses its Drug Compounds to Roche Subsidiary Genentech 01/29/13 San Diego
East Coast Life Sciences Roundup: Ariad, Pfizer, Cubist, More 01/25/13 Boston
Sanford-Burnham’s CEO Sees Incredible Opportunity in Move to Roche 01/16/13 San Diego
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More 01/11/13 Boston
Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 01/10/13 San Francisco
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
Prothena of South San Francisco Gets Head Start as Elan Spinoff 01/09/13 San Francisco
After Clinical Trial Setback, San Diego’s MediciNova Sets New Course 01/08/13 San Diego
Page 2 of 13 « previous page · next page »